GB9817075D0 - Determination of cellular growth abnormality - Google Patents

Determination of cellular growth abnormality

Info

Publication number
GB9817075D0
GB9817075D0 GBGB9817075.6A GB9817075A GB9817075D0 GB 9817075 D0 GB9817075 D0 GB 9817075D0 GB 9817075 A GB9817075 A GB 9817075A GB 9817075 D0 GB9817075 D0 GB 9817075D0
Authority
GB
United Kingdom
Prior art keywords
determination
cellular growth
growth abnormality
abnormality
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9817075.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9817075.6A priority Critical patent/GB9817075D0/en
Publication of GB9817075D0 publication Critical patent/GB9817075D0/en
Priority to EP98949123A priority patent/EP1025444B1/en
Priority to ES98949123T priority patent/ES2239407T3/en
Priority to AT98949123T priority patent/ATE290213T1/en
Priority to PE1998000991A priority patent/PE20000121A1/en
Priority to PT98949123T priority patent/PT1025444E/en
Priority to MA25308A priority patent/MA26557A1/en
Priority to BR9813127-3A priority patent/BR9813127A/en
Priority to CO98061237A priority patent/CO5080817A1/en
Priority to HU0004134A priority patent/HUP0004134A2/en
Priority to PL98340057A priority patent/PL340057A1/en
Priority to IL13560298A priority patent/IL135602A0/en
Priority to DE69829198T priority patent/DE69829198T2/en
Priority to NZ503996A priority patent/NZ503996A/en
Priority to JP11523482A priority patent/JP2000511291A/en
Priority to US09/175,947 priority patent/US6303323B1/en
Priority to CN98812478A priority patent/CN1282422A/en
Priority to GB9823069A priority patent/GB2332515B/en
Priority to CA002305872A priority patent/CA2305872C/en
Priority to AU95502/98A priority patent/AU751754B2/en
Priority to SK559-2000A priority patent/SK5592000A3/en
Priority to PCT/GB1998/003153 priority patent/WO1999021014A1/en
Priority to DK98949123T priority patent/DK1025444T3/en
Priority to IS5456A priority patent/IS5456A/en
Priority to NO20002044A priority patent/NO20002044L/en
Priority to US09/922,652 priority patent/US7056690B2/en
Priority to JP2003007249A priority patent/JP3774196B2/en
Priority to US11/365,659 priority patent/US7459157B2/en
Priority to US12/264,456 priority patent/US8148087B2/en
Priority to US13/406,761 priority patent/US8470544B2/en
Priority to US13/894,843 priority patent/US8609351B2/en
Ceased legal-status Critical Current

Links

GBGB9817075.6A 1997-10-21 1998-08-05 Determination of cellular growth abnormality Ceased GB9817075D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB9817075.6A GB9817075D0 (en) 1998-08-05 1998-08-05 Determination of cellular growth abnormality
DE69829198T DE69829198T2 (en) 1997-10-21 1998-10-21 PROOF OF CELL GROWTH ABNORMALITY
JP11523482A JP2000511291A (en) 1997-10-21 1998-10-21 Measurement of abnormal cell proliferation
GB9823069A GB2332515B (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
US09/175,947 US6303323B1 (en) 1997-10-21 1998-10-21 Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
PE1998000991A PE20000121A1 (en) 1997-10-21 1998-10-21 DETERMINATION OF ABNORMALITY IN CELLULAR GROWTH
PT98949123T PT1025444E (en) 1997-10-21 1998-10-21 DETERMINATION OF CELL GROWTH ANOMALY
MA25308A MA26557A1 (en) 1997-10-21 1998-10-21 DETERMINATION OF THE ABNORMAL CHARACTER OF CELL GROWTH
BR9813127-3A BR9813127A (en) 1997-10-21 1998-10-21 Process for determining the presence or absence of abnormally proliferating cells or abnormalities in cell growth, and, together
CO98061237A CO5080817A1 (en) 1997-10-21 1998-10-21 DETERMINATION OF ABNORMALITIES IN CELLULAR GROWTH
HU0004134A HUP0004134A2 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
PL98340057A PL340057A1 (en) 1997-10-21 1998-10-21 Determination of cell growth disorders
IL13560298A IL135602A0 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
ES98949123T ES2239407T3 (en) 1997-10-21 1998-10-21 DETERMINATION OF AN ABNORMALITY IN CELLULAR GROWTH.
NZ503996A NZ503996A (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
EP98949123A EP1025444B1 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
AT98949123T ATE290213T1 (en) 1997-10-21 1998-10-21 DETECTION OF CELL GROWTH ABNORMALITY
CN98812478A CN1282422A (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
DK98949123T DK1025444T3 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
CA002305872A CA2305872C (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
AU95502/98A AU751754B2 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
SK559-2000A SK5592000A3 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
PCT/GB1998/003153 WO1999021014A1 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
IS5456A IS5456A (en) 1997-10-21 2000-04-17 Determination of abnormal cell growth
NO20002044A NO20002044L (en) 1997-10-21 2000-04-18 Determination of abnormal cell growth
US09/922,652 US7056690B2 (en) 1997-10-21 2001-08-07 Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies
JP2003007249A JP3774196B2 (en) 1997-10-21 2003-01-15 Abnormal cell growth
US11/365,659 US7459157B2 (en) 1997-10-21 2006-03-02 Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies
US12/264,456 US8148087B2 (en) 1997-10-21 2008-11-04 Detection of dysplastic or neoplastic cells using anti-MCM6 antibodies
US13/406,761 US8470544B2 (en) 1997-10-21 2012-02-28 Detection of dysplastic or neoplastic cells using anti-MCM3 antibodies
US13/894,843 US8609351B2 (en) 1997-10-21 2013-05-15 Detection of dysplastic or neoplastic cells using anti-MCM4 antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9817075.6A GB9817075D0 (en) 1998-08-05 1998-08-05 Determination of cellular growth abnormality

Publications (1)

Publication Number Publication Date
GB9817075D0 true GB9817075D0 (en) 1998-10-07

Family

ID=10836772

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9817075.6A Ceased GB9817075D0 (en) 1997-10-21 1998-08-05 Determination of cellular growth abnormality

Country Status (1)

Country Link
GB (1) GB9817075D0 (en)

Similar Documents

Publication Publication Date Title
HUP0004134A2 (en) Determination of cellular growth abnormality
AP2001002071A0 (en) Phenyl yanthine derivatives
GB9803172D0 (en) Porous belts
GB9808772D0 (en) Poultice
GB2338783B (en) Frequency determination
GB2336500B (en) Radiotelephone
GB9818931D0 (en) Photobioreactor
GB2343104B (en) Carrying aid
GB9810560D0 (en) Determination of cellular growth abnormality
GB9817075D0 (en) Determination of cellular growth abnormality
GB9804156D0 (en) Determination of cellular growth abnormality
GB9724134D0 (en) Determination of cellular growth abnormality
GB9722217D0 (en) Determination of cellular growth abnormality
GB2332909B (en) Glycerol-based fluidifing substance
TW407485U (en) Bath band
GB9820406D0 (en) Growth factors
PL109026U1 (en) Cellular brick
TW354479U (en) Improvement of earpick
GB9825220D0 (en) Cellular mattress
CA84026S (en) Radiotelephone
GB9812317D0 (en) Biological factor
GB9826207D0 (en) Bone conditions
TW451752U (en) Improved structure of copper-extrusion conveyer
GB9823794D0 (en) Carrying aid
GB9827680D0 (en) Carrying aid

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)